Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126) — Cash Flow Quality Index
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126) has a Cash Flow Quality Index of 0.90x as of December 2024. Operating cash flow of CN¥24.04 Million is below net income of CN¥26.57 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore 301126 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd Cash Flow Quality Index (2019–2024)
Historical Cash Flow Quality Index for Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see 301126 cash flow metrics.
Annual Cash Flow Quality Index for Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (2019–2024)
Year-by-year earnings quality comparison for Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.90x | CN¥24.04 Million | CN¥26.57 Million | ▲ +14.4% |
| 2023 | 0.79x | CN¥27.13 Million | CN¥34.30 Million | ▲ +108.2% |
| 2022 | -9.66x | CN¥-493.96 Million | CN¥51.12 Million | ▼ -307.6% |
| 2021 | -2.37x | CN¥-161.81 Million | CN¥68.26 Million | ▼ -1.5% |
| 2020 | -2.34x | CN¥-151.46 Million | CN¥64.85 Million | ▼ -250.6% |
| 2019 | 1.55x | CN¥135.91 Million | CN¥87.65 Million | — |